featured
Patient-Reported Outcomes of PIK3CA-Mutated HR+, HER2− Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer From SOLAR-1
J. Clin. Oncol 2021 Mar 29;[EPub Ahead of Print], EM Ciruelos, HS Rugo, IA Mayer, C Levy, F Forget, JI Delgado Mingorance, T Safra, N Masuda, YH Park, D Juric, P Conte, M Campone, S Loibl, H Iwata, X Zhou, J Park, A Ridolfi, I Lorenzo, F AndréFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.